LENSAR, Inc. (LNSR)
USD 14.27
(10.02%)
USD 14.27
(10.02%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.3 Million USD | -17.62% |
| 2022 | 2.8 Million USD | 0.0% |
| 2021 | 2.8 Million USD | -15.42% |
| 2020 | 3.31 Million USD | -83.86% |
| 2019 | 20.53 Million USD | -50.18% |
| 2018 | 41.21 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.03 Million USD | -6.36% |
| 2024 Q1 | 2.17 Million USD | -5.98% |
| 2023 Q1 | 2.71 Million USD | -3.14% |
| 2023 FY | 2.3 Million USD | -17.62% |
| 2023 Q4 | 2.3 Million USD | -5.64% |
| 2023 Q3 | 2.44 Million USD | -5.23% |
| 2023 Q2 | 2.58 Million USD | -4.9% |
| 2022 Q3 | 2.93 Million USD | -4.15% |
| 2022 Q2 | 3.06 Million USD | -3.98% |
| 2022 Q1 | 3.18 Million USD | 13.74% |
| 2022 FY | 2.8 Million USD | 0.0% |
| 2022 Q4 | 2.8 Million USD | -4.46% |
| 2021 Q1 | 3.18 Million USD | -3.77% |
| 2021 FY | 2.8 Million USD | -15.42% |
| 2021 Q4 | 2.8 Million USD | -4.43% |
| 2021 Q3 | 2.93 Million USD | -4.18% |
| 2021 Q2 | 3.06 Million USD | -4.01% |
| 2020 Q4 | 3.31 Million USD | -3.66% |
| 2020 Q2 | 67.86 Million USD | 0.0% |
| 2020 Q3 | 3.44 Million USD | -94.93% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 3.31 Million USD | -83.86% |
| 2019 Q4 | 20.53 Million USD | 0.0% |
| 2019 FY | 20.53 Million USD | -50.18% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 41.21 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -44.765% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 92.048% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 94.113% |
| BioSig Technologies, Inc. | 452 Thousand USD | -410.841% |
| AxoGen, Inc. | 69.29 Million USD | 96.668% |
| DexCom, Inc. | 2.59 Billion USD | 99.911% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -122.804% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.863% |
| INVO Bioscience, Inc. | 8.68 Million USD | 73.41% |
| IRIDEX Corporation | 2.74 Million USD | 15.914% |
| MaxCyte, Inc. | 18.74 Million USD | 87.681% |
| Nuwellis, Inc. | 981 Thousand USD | -135.372% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -145.556% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.899% |
| Apyx Medical Corporation | 38.5 Million USD | 94.003% |
| PAVmed Inc | 48.72 Million USD | 95.261% |
| BIOLASE, Inc. | 17.91 Million USD | 87.108% |
| Biotricity, Inc. | 23.87 Million USD | 90.33% |
| BrainsWay Ltd. | 471 Thousand USD | -390.234% |
| Cerus Corporation | 95.99 Million USD | 97.595% |
| Envoy Medical, Inc. | 404 Thousand USD | -471.535% |
| RxSight, Inc. | 3.01 Million USD | 23.34% |
| Cutera, Inc. | 431.91 Million USD | 99.465% |
| Sintx Technologies, Inc. | 4.24 Million USD | 45.607% |
| Dynatronics Corporation | 6.68 Million USD | 65.475% |
| electroCore, Inc. | 626 Thousand USD | -268.85% |
| Telesis Bio, Inc. | 34.38 Million USD | 93.284% |
| FONAR Corporation | 41.67 Million USD | 94.46% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -3950.877% |
| iCAD, Inc. | 461 Thousand USD | -400.868% |
| IceCure Medical Ltd | 599 Thousand USD | -285.476% |
| Inogen, Inc. | 21.92 Million USD | 89.468% |
| InMode Ltd. | 9.01 Million USD | 74.393% |
| IRadimed Corporation | 2.04 Million USD | -13.018% |
| LivaNova PLC | 640.4 Million USD | 99.639% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 84.864% |
| Spectral AI, Inc. | 1.28 Million USD | -79.131% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -369.318% |
| Modular Medical, Inc. | 1.19 Million USD | -94.034% |
| Movano Inc. | 252 Thousand USD | -816.27% |
| NanoVibronix, Inc. | 5000.00 USD | -46080.0% |
| Inari Medical, Inc. | 32.04 Million USD | 92.795% |
| Nemaura Medical Inc. | 20.03 Million USD | 88.472% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -1152.169% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 72.499% |
| enVVeno Medical Corporation | 1.4 Million USD | -64.693% |
| Align Technology, Inc. | 96.96 Million USD | 97.619% |
| Outset Medical, Inc. | 136.18 Million USD | 98.305% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -130.439% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -69.153% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 97.085% |
| Profound Medical Corp. | 7.9 Million USD | 70.774% |
| Quipt Home Medical Corp. | 98.94 Million USD | 97.666% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 24.814% |
| Quanterix Corporation | 41.46 Million USD | 94.431% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 68.568% |
| SI-BONE, Inc. | 38.99 Million USD | 94.078% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 95.416% |
| TELA Bio, Inc. | 42.78 Million USD | 94.603% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -525.745% |
| Talis Biomedical Corporation | 19.66 Million USD | 88.26% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 96.716% |
| Vivani Medical, Inc. | 20.69 Million USD | 88.843% |
| Bruker Corporation | 1.37 Billion USD | 99.833% |
| Venus Concept Inc. | 79.69 Million USD | 97.103% |
| Viveve Medical, Inc. | 5.34 Million USD | 56.833% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 77.52% |
| ZimVie Inc. | 521.92 Million USD | 99.558% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 1.661% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 98.221% |
| Pulmonx Corporation | 41.42 Million USD | 94.426% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.574% |
| Axonics, Inc. | 27.61 Million USD | 91.639% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -781.298% |
| NeuroPace, Inc. | 72.39 Million USD | 96.811% |
| Nexalin Technology, Inc. | 4463.00 USD | -51636.5% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 85.23% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -15.739% |
| UFP Technologies, Inc. | 46.03 Million USD | 94.984% |
| Varex Imaging Corporation | 469.5 Million USD | 99.508% |
| PAVmed Inc. | 48.72 Million USD | 95.261% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.445% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 93.04% |
| 908 Devices Inc. | 5.94 Million USD | 61.161% |
| Nexalin Technology, Inc. | 4463.00 USD | -51636.5% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 83.437% |
| Orthofix Medical Inc. | 134.19 Million USD | 98.279% |
| Surmodics, Inc. | 29.4 Million USD | 92.148% |
| OrthoPediatrics Corp. | 23.76 Million USD | 90.282% |
| Semler Scientific, Inc. | 70 Thousand USD | -3198.571% |
| Cytosorbents Corporation | 18.31 Million USD | 87.392% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -15.652% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -15.652% |
| Sight Sciences, Inc. | 35.41 Million USD | 93.48% |
| Insulet Corporation | 1.44 Billion USD | 99.841% |
| Beyond Air, Inc. | 17.83 Million USD | 87.055% |
| Bioventus Inc. | 409.47 Million USD | 99.436% |
| InspireMD, Inc. | 1.59 Million USD | -44.765% |
| Tenon Medical, Inc. | 1.17 Million USD | -96.846% |
| CVRx, Inc. | 30.61 Million USD | 92.457% |
| Acutus Medical, Inc. | 38.47 Million USD | 93.999% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 22.791% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 1.661% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -194.891% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.753% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.552% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -21.335% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -858.584% |
| Hyperfine, Inc. | 185 Thousand USD | -1148.108% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 98.799% |
| Biomerica, Inc. | 785 Thousand USD | -194.14% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -413.701% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -523.877% |
| Silk Road Medical, Inc | 84.63 Million USD | 97.272% |